You are using an older browser version. Please use a supported version for the best MSN experience.

Pfizer submits COVID-19 vaccine trial data to FDA for children aged 5-11

Pfizer and BioNTech announced they have submitted results to the U.S. Food and Drug Administration from their coronavirus vaccine trial on children aged 5 to 11. According to a statement, the results showed a "favorable safety profile." Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, joined CBSN to discuss.

More From CBS News

More From CBS News

Latest News Video

More News Video Partners

image beaconimage beaconimage beacon